- Fee assured
- Verified this account
- Cataract Full Pathway provider
I offer Bupa customers standard cataract surgery on the Full Pathway package option at Optegra Eye Hospital Manchester .
This package includes your appointments before and after surgery, as well as your surgery and mono-focal lenses. It means you won’t use up your out-patient benefit or receive any additional bills from your surgeon (or anaesthetist, if you need one) for eligible treatment.
Please call the Bupa Eye Care team to find out more about and to pre-authorise your treatment on 0345 600 7267.
- Surgical retinal
I completed my medical degree in 1994 and then trained in Ophthalmology whilst working in St Paul’s Eye Unit in Liverpool. I subsequently specialised in Vitreo-Retinal surgery at Oxford Eye Hospital. I accepted my first consultant post in Oxford Eye Hospital. I then worked for a short period at Southampton University Hospital before accepting a substantive consultant post at the Countess of Chester Hospital in 2008. I was appointed to set up the Vitreo-Retinal Unit and the Medical Retina service which I successfully did in 2009.
Areas of interest
Cataract Surgery; Multifocal and Toric Lens implants; Refractive Lens Exchange; Medical Retinal Conditions - Age Related Macular Degeneration and Diabetic Retinopathy; Vitreo-retinal Surgery - Macular holes and Epiretinal Membranes.
Lens Implant for Macula Degeneration.
Anaesthetists worked with
Mr Sunildath Cazabon has worked with Dr Pavan Kochhar at the following hospitals:
- Optegra Eye Hospital Manchester (1-5)
Mr Sunildath Cazabon has worked with Dr Milda E Simpson at the following hospitals:
- Optegra Eye Hospital Manchester (1-5)
Current NHS consultant posts held
Consultant Ophthalmologist at the Countess of Chester Hospital.
Age Related Macular Degeneration.
Football, Cricket, Scuba diving and Running.
Local Clinical Excellence Awards.
1 Ali K, Owen M, Kumar I, Cazabon S. Streptococcus Pneumonaie Meningitis Following Endophthalmitis. Eye 2012;12:1593.
2 Ali K, Saeed MU, Cazabon S. A patient's perception of visual problems with epi-retinal membrane formation and subsequent surgical interventions. BMJ Case Reports Published 8th July 2011; doi:10.1136/bcr.05.2011.4253.
3 Cazabon S, Hillier R, Wong D. Heavy Silicone Oil: A “Novel” Intraocular Tamponade Agent. Optom Vis Sci 2011;88:772-75.
4 Singh AJ, Kendal A, Trivedi D, Cazabon S. Patient Expectation And Satisfaction After Macular Hole Surgery. Optometry and Vision Science 2011; 88 (2): 312-316.
5 Cazabon S, Quah SA, Jones MA, Batterbury, Kaye S. Sequential versus combined penetrating keratoplasty and cataract surgery. Optom Vis Sci 2010; 87(7): 482-6.
6 Cazabon S. Full Thickness Macular Hole Formation Associated With Pigment Epithelial Detachment: Link or Coincidence? International Ophthalmology. Online FirstTM 02 June 2010.
7 Cazabon S, Quah SA, Pearce IA, Harding SP. Uveitis Triggered by Acute Onset Gastro-enteritis. Int J Clin Pract 2008; 62(12): 1957-58
8 Gibran SK, Prime W, Cazabon S, Stappler T, Heimann H, Pearce I, Groenewald C, Wong D, Hiscott P. Successful retrieval of internal limiting membrane specimens. Eye 2007; 21(2): 298-9
9 Hillier R, Cazabon S, Wong D. The Emerging Role of Heavy Silicone Oil as a Tamponade Agent. Eye News 2007; 13(4): 14-17
10 Quah SA, Cazabon S, Porooshani H, Pearce IA. Visual Loss Following Laser Photoablation of Peripapillary Choroidal Neovascular Membrane. Asian J Ophthalmol 2006; 8: 252-53
11 Wong D, Cazabon S, Ali H, Kumar I, Valldeperas X, Groenewald C, Pearce IA. Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of Proliferative Vitreoretinopathy? Annals of the Academy of Medicine 2006; 35(3): 181-84
12 Cazabon S, Groenewald C, Pearce IA, Wong D. Loss of Visual Acuity Following Removal of Silicone Oil. BJO 2005; 89(7): 799-802
13 Cazabon S, Over K, Butcher JM. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye 2005; 19(2): 222-4
14 Cazabon S, Hagan R, Khan J, Groenewald C, Wong D. Loss of visual acuity following removal of intraocular silicone oil. Invest Ophthalmol Vis Sci (ARVO Abstract). 2004; 2071/B882
Reference number 4388454
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.